Accession Number: | 0001209191-19-037564 |
Date: | 2019-06-13 |
Issuer: | CONCERT PHARMACEUTICALS, INC. (CNCE) |
Original Submission Date: |
HUTT PETER BARTON
C/O CONCERT PHARMACEUTICALS, INC.
65 HAYDEN AVENUE, SUITE 3000N
LEXINGTON, MA 02421
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NONSTATUTORY STOCK OPTION (RIGHT TO BUY) | 11.02 | 2019-06-13 | deemed execution date | A | 10,000 (a) | 2029-06-12 | common stock 10,000 | $11.02 | 10,000 | direct |
ID | footnote |
---|---|
f1 | the shares underlying this option vest in equal quarterly installments over a one-year period, through and including june 13, 2020. |